Managers / Q2 2024 · view latest →
Insight Inv LLC
CIK 0001909322 · 330 ILLINOIS STREET, EL SEGUNDO, CA, 90245 · 310-426-6322
Summary
Insight Inv LLC reported $116M in U.S.-listed holdings across 88 positions for Q2 2024.
Its largest position, AAPL, represents 5.3% of the portfolio.
Compared with Q1 2024, the fund opened 1 new position and exited 2.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 89.6% · $104M
- ETP · 6.5% · $7M
- Other · 2.3% · $3M
- ADR · 1.4% · $2M
- Closed-End Fund · 0.2% · $255,698
Quarter-over-Quarter Changes full breakdown →
vs Q1 2024 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| LHLABCORP HOLDINGS INC | NEW | +3.5K | 3.5K | +$718,390 | $718,390 |
| LABORATORY CORP AMER HLDGS | SOLD OUT | −3.5K | 0 | −$761,333 | $0 |
| BITOPROSHARES TR | SOLD OUT | −7.0K | 0 | −$224,485 | $0 |
| EOGEOG RES INC | ADDED | +3.5K | 9.3K | +$434,213 | $1M |
| FIRST TR EXCHANGE-TRADED FD | ADDED | +2.7K | 10.2K | +$129,442 | $489,870 |
| CVSCVS HEALTH CORP | TRIMMED | −2.7K | 14.9K | −$523,575 | $879,403 |
| PARAMOUNT GLOBAL | TRIMMED | −3.2K | 18.9K | −$63,837 | $197,681 |
| BMYBRISTOL-MYERS SQUIBB CO | TRIMMED | −2.1K | 22.7K | −$401,804 | $941,527 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2024
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $183M | 104 | Apr 28, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $178M | 112 | Feb 6, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $170M | 112 | Oct 28, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $149M | 116 | Jul 24, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $145M | 133 | Apr 25, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $144M | 124 | Jan 21, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $119M | 89 | Nov 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $116M | 88 | Aug 7, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $115M | 89 | Apr 29, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $102M | 87 | Jan 22, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $90M | 86 | Oct 30, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $97M | 88 | Aug 9, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $93M | 88 | May 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $99M | 97 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $90M | 99 | Nov 9, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $99M | 163 | Aug 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $110M | 100 | May 10, 2022 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.